title: Onset of analgesia with ibuprofen sodium in tension-type headache: a randomized trial.
abstract: BACKGROUND
  Ibuprofen is known to be efficacious in the treatment of tension-type headache, the most common form of primary headache. A novel tablet formulation of ibuprofen sodium is more rapidly absorbed than standard ibuprofen. This study evaluated onset of analgesia and overall efficacy of ibuprofen sodium in episodic-type tension headache (ETTH) compared with standard ibuprofen and placebo.
  
  
  METHODS
  This randomized, double-blind, single-center, parallel-group study included adults aged 18-65 years with ≥4 moderately severe ETTHs per month for 6 months. Within 45 minutes of onset of at least moderately severe ETTH, subjects were randomized 2:2:1 to receive a single oral dose of ibuprofen sodium tablets (Advil® Film Coated; 2 × 256 mg [equivalent to 400 mg standard ibuprofen]), standard ibuprofen tablets (Motrin®; 2 × 200 mg), or placebo. The coprimary end points were time-weighted sum of pain relief rating and pain intensity difference scores over 3 hours (SPRID 0-3) and time to meaningful pain relief (MPR) assessed by double-stopwatch method.
  
  
  RESULTS
  A total of 226 subjects were randomized to ibuprofen sodium (n = 91), standard ibuprofen (n = 89), and placebo (n = 46). Demographics and baseline characteristics were comparable between treatment groups. Mean SPRID 0-3 scores were significantly superior (P < .001) for ibuprofen sodium (9.6) and standard ibuprofen (9.8) versus placebo (3.5), but were not significantly different from each other (P = .812). Time to MPR was significantly (P < .001) shorter for ibuprofen sodium and standard ibuprofen compared with placebo (median 40.6, 48.5, and >180 minutes, respectively). Time to MPR was numerically faster for ibuprofen sodium than standard ibuprofen. This difference was not statistically significant (P = .253) using the protocol-specified analysis but was (P = .022) in a post hoc analysis using the Gehan-Wilcoxon test, which assigns higher weights to earlier events. (The post hoc analysis was performed because Kaplan-Meier graphs and results for time to first perceptible relief favored ibuprofen sodium over standard ibuprofen at earlier time points.) There were no adverse events.
  
  
  CONCLUSIONS
  This novel ibuprofen sodium tablet provided rapid, efficacious relief of ETTH and was well tolerated.
  
  
  BACKGROUND
  ClinicalTrials.gov NCT01362491.
authors.affiliation: Institute for Applied Pharmaceutical Research, 214 Sycamore Avenue, Merion Station, PA 19066 USA.
authors.forename: Elias
authors.initials: E
authors.lastname: Packman
authors.affiliation: Pfizer Consumer Healthcare, 1 Giralda Farms, Madison, NJ 07940 USA.
authors.forename: Rina
authors.initials: R
authors.lastname: Leyva
authors.affiliation: Pfizer Consumer Healthcare, 1 Giralda Farms, Madison, NJ 07940 USA.
authors.forename: David
authors.initials: D
authors.lastname: Kellstein
keywords: Analgesia; Fast-absorbed ibuprofen; Ibuprofen sodium; Over the counter; Tension headache
references.citation: Drugs R D. 2014 Dec;14(4):283-90
references.pmid: 25395311
references.citation: Int J Clin Pharmacol Ther. 2007 Feb;45(2):89-97
references.pmid: 17323788
references.citation: Br J Anaesth. 2005 May;94(5):642-8
references.pmid: 15790675
references.citation: J Clin Pharmacol. 2002 Aug;42(8):904-11
references.pmid: 12162473
references.citation: Clin Ther. 2002 Jul;24(7):1072-89
references.pmid: 12182253
references.citation: J Oral Surg. 1977 Nov;35(11):898-903
references.pmid: 269932
references.citation: Inflammopharmacology. 2012 Aug;20(4):233-42
references.pmid: 22287037
references.citation: J Clin Pharmacol. 1989 Jun;29(6):550-3
references.pmid: 2666455
references.citation: Eur J Clin Pharmacol. 2002 Sep;58(6):387-94
references.pmid: 12242597
references.citation: Clin Pharmacol Ther. 2000 Sep;68(3):312-9
references.pmid: 11014413
references.citation: Cephalalgia. 2004;24 Suppl 1:9-160
references.pmid: 14979299
references.citation: Clin Pharmacol Ther. 1988 Dec;44(6):704-11
references.pmid: 3197368
references.citation: Clin Pharmacol Ther. 1986 Jul;40(1):1-7
references.pmid: 3522030
references.citation: Anesth Analg. 2003 Jul;97(1):163-7, table of contents
references.pmid: 12818960
references.citation: J Epidemiol Community Health. 1992 Aug;46(4):443-6
references.pmid: 1431724
references.citation: Int J Clin Pharmacol Ther. 2005 Mar;43(3):140-9
references.pmid: 15792398
references.citation: Clin Ther. 2010 Dec;32(14):2348-69
references.pmid: 21353105
references.citation: J Clin Pharmacol. 1989 Nov;29(11):1026-30
references.pmid: 2689471
references.citation: Int J Clin Pharmacol Ther. 2011 Dec;49(12):722-9
references.pmid: 22122814
references.citation: Headache. 2000 Jul-Aug;40(7):561-7
references.pmid: 10940094
references.citation: J Clin Pharmacol. 1996 Dec;36(12):1120-5
references.pmid: 9013368
references.citation: Clin J Pain. 2015 May;31(5):444-50
references.pmid: 25119511